AMY CAVNER: Open Payments
NPI 1427712421 · KINGFISHER, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$911 in 24 payments from 13 companies in 2025. Trend: 2023 $464 · 2024 $1,083 · 2025 $911
Food & beverage: $911
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 2 | $265 |
| AstraZeneca Pharmaceuticals LP | 5 | $186 |
| Dexcom, Inc. | 1 | $162 |
| Exact Sciences Corporation | 3 | $50 |
| Novo Nordisk Inc | 2 | $43 |
| Phathom Pharmaceuticals, Inc. | 3 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $34 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Lundbeck LLC | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $22 |
Products named: SPRAVATO, DEXCOM G7 GSS (161), BREZTRI, REXULTI, The Cologuard Plus Collection Kit, VOQUEZNA, FARXIGA, CAPLYTA.
Industry payments across OK — which companies pay providers there.
